Mga Batayang Estadistika
| LEI | 549300ZPKZIG6DKDEC02 |
| CIK | 877860 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to National Health Investors, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 6, 2025 |
a82025businessupdate2 National Health Investors Investor Update August 6, 2025 CountryHouse in Elkhorn operated by Agemark Senior Living Disclaimers This presentation, as well as information included in oral statements made, or to be made, by our senior management contain forward- looking statements that are based on current expectations, estimates, beliefs and assumptions. |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2025 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 6, 2025 |
NHI Announces Second Quarter 2025 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Second Quarter 2025 Results MURFREESBORO, Tenn. – (Wednesday, August 6, 2025) National Health Investors, Inc. (NYSE: NHI) announced today its results for the three and six months ended June 30, 2025. CEO Comments “We had another great quarter which exceeded our expectations. Given the strong quarterly |
|
| August 6, 2025 |
Exhibit 4.1 NATIONAL HEALTH INVESTORS, INC., AS ISSUER THE GUARANTEEING SUBSIDIARIES PARTY HERETO, THE SUBSIDIARY GUARANTORS PARTY HERETO, AS SUBSIDIARY GUARANTORS AND REGIONS BANK, AS TRUSTEE THIRD SUPPLEMENTAL INDENTURE Dated as of July 7, 2025 SUPPLEMENT TO INDENTURE DATED AS OF JANUARY 26, 2021, BETWEEN NATIONAL HEALTH INVESTORS, INC. (AS ISSUER) AND REGIONS BANK (AS TRUSTEE) THIRD SUPPLEMENTA |
|
| August 6, 2025 |
Amendment to Articles of Incorporation approved by stockholders on May 21, 2025 Exhibit 3.6 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF NATIONAL HEALTH INVESTORS, INC. NATIONAL HEALTH INVESTORS, INC., a Maryland corporation, hereby certifies to the State Department of Assessments and Taxation of Maryland that its Articles of Incorporation, as amended (the “Articles”) are hereby amended as follows: 1.Section 6.1 of the Articles shall be deleted in its entirety and is |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): August 6, 2025 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissio |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2025 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 6, 2025 |
ex991-q22025supplemental National Health Investors Q2 2025 Supplemental TABLE OF CONTENTS 1 Q2 2025 COVER: COUNTRYHOUSE IN ELKHORN IS A MEMORY CARE COMMUNITY IN ELKHORN, NE OPERATED BY AGEMARK SENIOR LIVING. |
|
| August 6, 2025 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (August 6, 2025) - National Health Investors, Inc. (NYSE: NHI) has issued the following investor update which can be found at: https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx About NHI Incorporated in 1991, National Health |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Healt |
|
| June 2, 2025 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, TN / ACCESS Newswire / June 2, 2025 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor presentation which can be found at: https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx The presentation updates NHI's |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): June 2, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 2, 2025 |
National Health Investors Investor Update, June 2, 2025 Exhibit 99.2 |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 21, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| May 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 5, 2025 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 5, 2025 |
National Health Investors Investor Update, Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 5, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 5, 2025 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (May 5, 2025) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx About NHI Incorporated in 1991, National Health Inve |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Heal |
|
| May 5, 2025 |
NHI Announces First Quarter 2025 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2025 Results MURFREESBORO, Tenn. – (Monday, May 5, 2025) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common share for the t |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| May 5, 2025 | ||
| May 5, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 5, 2025 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| April 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| April 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| April 7, 2025 |
ANNUAL REPORT Dear Fellow Stockholders – On behalf of our Board of Directors and everyone at NHI, I want to thank you for your continued investment and confidence in the Company. |
|
| April 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confid |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ x ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as per |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): March 27, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission |
|
| March 27, 2025 |
NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors MURFREESBORO, Tenn.- (March 27, 2025) - National Health Investors, Inc. (NYSE:NHI) (the “Company” or “NHI”) announced today that Robert W. Chapin, Jr. is joining the NHI Board of Directors (the “Board”) effective immediat |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): March 27, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commiss |
|
| March 27, 2025 |
NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors MURFREESBORO, Tenn.- (March 27, 2025) - National Health Investors, Inc. (NYSE:NHI) (the “Company” or “NHI”) announced today that Robert W. Chapin, Jr. is joining the NHI Board of Directors (the “Board”) effective immediat |
|
| March 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confide |
|
| February 25, 2025 |
Exhibit 21 Subsidiary Entity List Entity Name Ownership1 Tax Treatment NHI/REIT, Inc. |
|
| February 25, 2025 | ||
| February 25, 2025 |
EXECUTION VERSION Published CUSIP Number: 63633KAX6 Facility CUSIP Number: 63633KAX6 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of October 24, 2024 by and among NATIONAL HEALTH INVESTORS, INC. |
|
| February 25, 2025 |
NHI Announces Fourth Quarter 2024 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Fourth Quarter 2024 Results MURFREESBORO, Tenn. – (Tuesday, February 25, 2025) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2024. Financial Results and Recent Events •Net income attributable to common stockholders per diluted |
|
| February 25, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2025 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 25, 2025 |
National Health Investors, Inc. Insider Trading Policy As amended through January 30, 2025 TO: NHI Directors, Officer and Employees FROM: NHI Board of Directors DATE: January 30, 2025 SUBJECT: Insider Trading Policy The federal securities laws prohibit (i) the purchase or sale of a company’s securities by persons who are aware of material nonpublic information about that company (“MNPI”) and (ii) |
|
| February 25, 2025 |
EXECUTION VERSION AMENDMENT NO. 1 TO TERM LOAN AGREEMENT This AMENDMENT NO. 1 TO TERM LOAN AGREEMENT (this “Amendment”) is made and entered into as of October 24, 2024 by and among NATIONAL HEALTH INVESTORS, INC., a corporation formed under the laws of the State of Maryland (the “Borrower”), each of the financial institutions signatory hereto as Lenders (as defined below), and WELLS FARGO BANK, NA |
|
| February 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Health In |
|
| February 25, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2025 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 25, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): February 25, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| February 25, 2025 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (February 25, 2025) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a rea |
|
| February 25, 2025 |
National Health Investors Investor Update, Exhibit 99.2 |
|
| February 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| February 10, 2025 |
NHI Announces Retirement of Robert Webb from the Board of Directors Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Announces Retirement of Robert Webb from the Board of Directors MURFREESBORO, Tenn.- (February 7, 2025) - National Health Investors, Inc. (NYSE:NHI) announced today that after more than 34 years of leadership and guidance on the NHI Board of Directors, Robert Webb has notified the Board that h |
|
| February 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported) February 10, 2025 (February 7, 2025) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorp |
|
| January 8, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): January 8, 2025 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission |
|
| January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): January 8, 2025 (December 2, 2024) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incor |
|
| January 8, 2025 |
NHI Announces Updates to Corporate Governance EXHIBIT 99.1 Contact: Dana Hambly, Vice President, Finance and Investor Relations Phone: (615) 890-9100 NHI Announces Updates to Corporate Governance MURFREESBORO, TN -(January 8, 2025) – National Health Investors, Inc. (NYSE:NHI) announced a series of changes to the Board of Directors which enhances the Board’s ability to provide strategic and independent guidance. The changes include the followi |
|
| December 2, 2024 |
NHI Announces Appointment of Candice Todd to the Board of Directors Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Announces Appointment of Candice Todd to the Board of Directors MURFREESBORO, Tenn. |
|
| December 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): December 2, 2024 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissio |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National |
|
| November 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 5, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 5, 2024 |
NHI Announces Third Quarter 2024 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Third Quarter 2024 Results MURFREESBORO, Tenn. – (Tuesday, November 5, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2024. Financial Results and Recent Events •Net income attributable to common stockholders per diluted com |
|
| November 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): November 5, 2024 (November 1, 2024) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorp |
|
| November 5, 2024 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (November 5, 2024) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real |
|
| November 5, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 5, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 5, 2024 | ||
| November 5, 2024 |
NHI Announces Retirement of W. Andrew Adams from the Board of Directors Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Announces Retirement of W. Andrew Adams from the Board of Directors MURFREESBORO, Tenn.- (November 5, 2024) - National Health Investors, Inc. (NYSE:NHI) announced today that after more than 30 years of leadership, W. Andrew “Andy” Adams has notified the Board of Directors of National Health In |
|
| November 5, 2024 | ||
| November 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): November 5, 2024 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissio |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2024 NATIONAL HEALTH INVESTORS, INC. (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (C |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): August 14, 2024 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission |
|
| August 16, 2024 |
Exhibit 1.4 REGISTERED FORWARD CONFIRMATION Date: August 14, 2024 To: National Health Investors, Inc. 222 Robert Rose Drive Murfresboro, Tennessee 37129 From: Wells Fargo Bank, National Association 30 Hudson Yards New York, New York 10001 Re: Registered Forward Transaction Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and condition |
|
| August 16, 2024 |
Exhibit 1.1 NATIONAL HEALTH INVESTORS, INC. (a Maryland corporation) 2,400,000 Shares of Common Stock UNDERWRITING AGREEMENT Dated: August 14, 2024 NATIONAL HEALTH INVESTORS, INC. (a Maryland corporation) 2,400,000 Shares of Common Stock UNDERWRITING AGREEMENT August 14, 2024 BofA Securities, Inc. One Bryant Park New York, New York 10036 J.P. Morgan Securities LLC 383 Madison Avenue New York, New |
|
| August 16, 2024 |
Exhibit 1.5 REGISTERED FORWARD CONFIRMATION Date: August 14, 2024 To: National Health Investors, Inc. 222 Robert Rose Drive Murfresboro, Tennessee 37129 From: Bank of Montreal 55 Bloor Street West, 18th Floor Toronto, Ontario M4W 1A5 Re: Registered Forward Transaction Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the tr |
|
| August 16, 2024 |
Exhibit 1.3 REGISTERED FORWARD CONFIRMATION Date: August 14, 2024 To: National Health Investors, Inc. 222 Robert Rose Drive Murfresboro, Tennessee 37129 From: JPMorgan Chase Bank, National Association 383 Madison Avenue New York, New York 10179 Re: Registered Forward Transaction Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and con |
|
| August 16, 2024 |
Exhibit 1.2 REGISTERED FORWARD CONFIRMATION Date: August 14, 2024 To: National Health Investors, Inc. 222 Robert Rose Drive Murfresboro, Tennessee 37129 From: Bank of America, N.A. c/o BofA Securities, Inc. Bank of America Tower at One Bryant Park New York, New York 10036 Re: Registered Forward Transaction Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) i |
|
| August 15, 2024 |
Exhibit 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) National Health Investors, Inc. |
|
| August 15, 2024 |
2,400,000 Shares National Health Investors, Inc. Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-270557 P R O S P E C T U S S U P P L E M E N T (To Prospectus dated March 15, 2023) 2,400,000 Shares National Health Investors, Inc. Common Stock We expect to enter into forward sale agreements with BofA Securities, Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and BMO Capital Markets Corp., or their respective affiliates (the “ |
|
| August 14, 2024 |
Subject to Completion Preliminary Prospectus Supplement dated August 14, 2024 424B5 Table of Contents The information in this preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but is not complete and may be changed. |
|
| August 6, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Healt |
|
| August 6, 2024 |
National Health Investors Investor Update Exhibit 99.2 |
|
| August 6, 2024 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (August 6, 2024) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real e |
|
| August 6, 2024 | ||
| August 6, 2024 |
NHI Announces Second Quarter 2024 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Second Quarter 2024 Results MURFREESBORO, Tenn. – (Tuesday, August 6, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2024. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common sha |
|
| August 6, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): August 6, 2024 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission |
|
| August 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| May 29, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 29, 2024 (May 22, 2024) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Submitted Pursuant to Rule 14a-6(g) (Amendment No. ) 1. Name of the Registrant: National Health Investors, Inc. 2. Name of Person Relying on Exemption: Land & Buildings Capital Management, LLC 3. Address of Person Relying on Exemption: Soundview Plaza 1266 E Main St., Suite 700R Stamford, Connecti |
|
| May 15, 2024 |
PRESENTATION, DATED MAY 15, 2024 2 1) Undervaluation at 14x 2025e AFFO 2) Well-covered nearly 6% dividend yield 3) Big senior housing (“SHOP”) growth potential 4) Accretive external growth opportunities 5) Material upside in under-rented senior housing and skilled nursing net lease portfolios 6) Long-term earnings power is substantially above today’s depressed levels 8 NHI’s poor corporate governance practices, including a classi |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Submitted Pursuant to Rule 14a-6(g) (Amendment No. ) 1. Name of the Registrant: National Health Investors, Inc. 2. Name of Person Relying on Exemption: Land & Buildings Capital Management, LLC 3. Address of Person Relying on Exemption: Soundview Plaza 1266 E Main St., Suite 700R Stamford, Connecti |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 6, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 6, 2024 | ||
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Heal |
|
| May 6, 2024 |
NHI Announces First Quarter 2024 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2024 Results MURFREESBORO, Tenn. – (Monday, May 6, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2024. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common share for the t |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 6, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 6, 2024 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 6, 2024 | ||
| May 6, 2024 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (May 6, 2024) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real esta |
|
| April 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Submitted Pursuant to Rule 14a-6(g) (Amendment No. ) 1. Name of the Registrant: National Health Investors, Inc. 2. Name of Person Relying on Exemption: Land & Buildings Capital Management, LLC 3. Address of Person Relying on Exemption: Soundview Plaza 1266 E Main St., Suite 700R Stamford, Connecti |
|
| April 4, 2024 |
2023 NATIONAL HEALTH INVESTORS ANNUAL REPORT Letter from our President and CEO Dear Fellow Stockholders - On behalf of our Board of Directors and everyone at NHI, I want to thank you for your continued investment and confidence in the Company as we have transitioned NHI through our portfolio optimization and are now in position to reignite growth through organic and external growth initiatives. |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| February 26, 2024 |
Exhibit 10.3 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of February 26, 2024 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”), and Kevin C. Pascoe (the “Executive”). W I T N E S S E T H WHEREAS, the Executive currently serves as a key employee of the Company and |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): February 26, 2024 (February 26, 2024) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of inco |
|
| February 26, 2024 |
Exhibit 10.1 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of February 26, 2024 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”), and D. Eric Mendelsohn (the “Executive”). W I T N E S S E T H WHEREAS, the Executive currently serves as a key employee of the Company |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-1082 |
|
| February 26, 2024 |
Exhibit 10.4 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of February 26, 2024 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”), and John L. Spaid (the “Executive”). W I T N E S S E T H WHEREAS, the Executive currently serves as a key employee of the Company and h |
|
| February 26, 2024 |
Exhibit 10.2 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of February 26, 2024 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”), and Kristin S. Gaines (the “Executive”). W I T N E S S E T H WHEREAS, the Executive currently serves as a key employee of the Company a |
|
| February 26, 2024 |
Senior Living Communities, LLC and Subsidiaries Financial Statements as of December 31, 202 SENIOR LIVING COMMUNITIES, LLC AND SUBSIDIARIES Charlotte, North Carolina Consolidated Financial Statements At December 31, 2023 and 2022 And For the Years Ended December 31, 2023, 2022, and 2021 * * * * * * * TABLE OF CONTENTS Financial Statements: Page Independent Auditor’s Report 2-3 Consolidated Balance Sheets 4-5 Consolidated Statements of Operations 6 Consolidated Statements of Changes in |
|
| February 26, 2024 |
Exhibit 10.5 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of February 26, 2024 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”), and David L. Travis (the “Executive”). W I T N E S S E T H WHEREAS, the Executive currently serves as a key employee of the Company and |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Health In |
|
| February 20, 2024 |
Exhibit 4.7 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the capital stock of National Health Investors, Inc. (the “Company,” “us,” “our” or “we”) is a summary of the rights of our common stock and certain provisions of Maryland General Corporation Law and our articles of incorporation, as amended (our “articles”) a |
|
| February 20, 2024 |
National Health Investors, Inc. Incentive Compensation Recovery Policy Exhibit 97 National Health Investors, Inc. Incentive Compensation Recovery Policy Adopted by the Board of Directors on November 3, 2023 The Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of National Health Investors, Inc. (the “Company”) is recommending to the Board that the Board adopt this Incentive Compensation Recovery Policy (this “Policy”) to provide for the |
|
| February 20, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 20, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 20, 2024 |
Exhibit 21 Subsidiary Entity List Entity Name Ownership1 Tax Treatment NHI/REIT, Inc. |
|
| February 20, 2024 |
NHI Announces Fourth Quarter 2023 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Fourth Quarter 2023 Results MURFREESBORO, Tenn. – (February 20, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2023. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common sh |
|
| February 20, 2024 | ||
| February 20, 2024 |
National Health Investors Progress Report, Exhibit 99.2 |
|
| February 20, 2024 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (February 20, 2024) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a rea |
|
| February 20, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): February 20, 2024 (February 20, 2024) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of inco |
|
| February 20, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 20, 2024 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 13, 2024 |
NHI / National Health Investors, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01513-nationalhealthinvest.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 18)* Name of issuer: National Health Investors Inc Title of Class of Securities: Common Stock CUSIP Number: 63633D104 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate |
|
| November 7, 2023 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (November 7, 2023) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National |
|
| November 7, 2023 |
National Health Investors Progress Report, Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 Exhibit 99.2 |
|
| November 7, 2023 | ||
| November 7, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 7, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 7, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): November 7, 2023 (November 7, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorp |
|
| November 7, 2023 |
NHI Announces Third Quarter 2023 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Third Quarter 2023 Results MURFREESBORO, Tenn. – (November 7, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2023. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common share |
|
| August 9, 2023 |
As filed with the Securities and Exchange Commission on August 9, 2023 As filed with the Securities and Exchange Commission on August 9, 2023 Registration No. |
|
| August 9, 2023 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) National Health Investors, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Fee Calculation Rule Amount Registered1 Proposed Maximum Offering Price Per Unit3 Maximum Aggregate Offering Price3 Fee Rate Amount of Registration Fee Equity Other 3,000,0002 $54.67 $164,010,00 |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 8, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 8, 2023 | ||
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Healt |
|
| August 8, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): August 8, 2023 (August 8, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporat |
|
| August 8, 2023 |
Exhibit 99.2 |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 8, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 8, 2023 |
NHI Announces Second Quarter 2023 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Second Quarter 2023 Results MURFREESBORO, Tenn. – (August 8, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2023. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common share for th |
|
| August 8, 2023 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (August 8, 2023) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real e |
|
| June 20, 2023 |
EXHIBIT 10.1 EXECUTION VERSION Published CUSIP Number: Term Loan CUSIP Number: TERM LOAN AGREEMENT Dated as of June 16, 2023 by and among NATIONAL HEALTH INVESTORS, INC., as Borrower, THE FINANCIAL INSTITUTIONS PARTY HERETO AND THEIR ASSIGNEES UNDER SECTION 12.5., as Lenders, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, BANK OF AMERICA, N.A., BANK OF MONTREAL, JPMORGAN CHASE BA |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): June 20, 2023 (June 16, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporatio |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 9, 2023 (May 9, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) ( |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Heal |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 9, 2023 | ||
| May 9, 2023 |
Exhibit 99.2 |
|
| May 9, 2023 |
NHI Announces First Quarter 2023 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2023 Results MURFREESBORO, Tenn. – (May 9, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2023. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common share for the three mon |
|
| May 9, 2023 |
Amended and Restated Bylaws as approved February 17, 2023, as amended April 27, 2023 AMENDED AND RESTATED BYLAWS OF NATIONAL HEALTH INVESTORS, INC. As adopted February 17, 2023 And as amended April 27, 2023 i AMENDED AND RESTATED BYLAWS OF NATIONAL HEALTH INVESTORS, INC. TABLE OF CONTENTS Page ARTICLE I MEETINGS OF STOCKHOLDERS 1 1.01. PLACE; REMOTE COMMUNICATION 1 1.02. ANNUAL MEETING 1 1.03. SPECIAL MEETINGS 1 1.04. NOTICE 2 1.05. SCOPE OF NOTICE 2 1.06. QUORUM 2 1.07. VOTING 2 |
|
| May 9, 2023 |
EX-99.1 2 exhibit991.htm EX-99.1 PRESS RELEASE Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (May 9, 2023) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx Incor |
|
| May 9, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 9, 2023 (May 5, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) ( |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| April 27, 2023 |
Amendment No. 1 to Amended and Restated Bylaws dated April Item 3.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED BYLAWS OF NATIONAL HEALTH INVESTORS, INC. As adopted April 27, 2023 The Amended and Restated Bylaws (the “Bylaws”) of National Health Investors, Inc. which were approved by the Board of Directors on February 17, 2023 are hereby amended as follows: 1. Section 1.03 of the Bylaws is hereby replaced with the following, which is marked to show what is be |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): April 27, 2023 (April 27, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporat |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permi |
|
| March 16, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 16, 2023 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| March 16, 2023 |
Exhibit 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) National Health Investors Inc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid Equity Common Stock, par value $0. |
|
| March 16, 2023 |
EX-1.1 Exhibit 1.1 NATIONAL HEALTH INVESTORS, INC. (a Maryland corporation) $500,000,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT Dated: March 16, 2023 TABLE OF CONTENTS Page SECTION 1. DESCRIPTION OF SECURITIES. 2 SECTION 2. PLACEMENTS. 5 SECTION 3. SALE OF SECURITIES TO OR THROUGH THE AGENTS. 5 SECTION 4. SUSPENSION OF SALES. 6 SECTION 5. REPRESENTATIONS AND WARRANTIES. 6 SECTION 6. SALE AN |
|
| March 16, 2023 |
FORM OF REGISTERED FORWARD CONFIRMATION EX-99.1 Exhibit 99.1 FORM OF REGISTERED FORWARD CONFIRMATION Date: [•], 20[•] To: National Health Investors, Inc. 222 Robert Rose Drive Murfresboro, Tennessee 37129 From: [DEALER NAME AND NOTICE INFORMATION] Re: Registered Forward Transaction Ladies and Gentlemen: The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction entered into betwe |
|
| March 16, 2023 |
$500,000,000 National Health Investors, Inc. Common Stock 424B5 1 d452026d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Number 333-270557 PROSPECTUS SUPPLEMENT (to Prospectus dated March 15, 2023) $500,000,000 National Health Investors, Inc. Common Stock We entered into an equity distribution agreement with each of BMO Capital Markets Corp., BofA Securities, Inc., Capital One Securities, Inc., Huntington Securities, Inc. |
|
| March 15, 2023 |
Statement of Eligibility of Trustee for Debt Securities on Form T-1. EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) REGIONS BANK (Exact name of trustee as specified in its charter) Alabama 63-0371391 (Jurisdict |
|
| March 15, 2023 |
List of Subsidiary Guarantors. EX-22.1 Exhibit 22.1 List of Subsidiary Guarantors As of the date of the registration statement of which this Exhibit 22.1 is a part, the 3.000% Senior Notes due 2031 of National Health Investors, Inc. (the “Company”) were fully and unconditionally guaranteed, jointly and severally, by each of the following subsidiaries of the Company: NHI/REIT, Inc. Florida Holdings IV, LLC NHI REIT of Alabama, L |
|
| March 15, 2023 |
Power of Attorney (included on signature page hereto). S-3ASR Table of Contents As filed with the Securities and Exchange Commission on March 15, 2023 Registration No. |
|
| March 15, 2023 |
EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) National Health Investors, Inc. |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-1082 |
|
| February 27, 2023 |
Exhibit 99.1 SENIOR LIVING COMMUNITIES, LLC AND SUBSIDIARIES Charlotte, North Carolina Consolidated Financial Statements At December 31, 2022 and 2021 And For the Years Ended December 31, 2022, 2021, and 2020 * * * * * * * TABLE OF CONTENTS Page Financial Statements: Independent Auditor’s Report 2-3 Consolidated Balance Sheets 4-5 Consolidated Statements of Operations 6 Consolidated Statements of |
|
| February 21, 2023 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Investor Update MURFREESBORO, Tenn.- (February 21, 2023) - National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a rea |
|
| February 21, 2023 |
Exhibit 21 Subsidiary Entity List Entity Name Ownership1 Tax Treatment NHI/REIT, Inc. |
|
| February 21, 2023 |
Exhibit 99.2 |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 21, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): February 21, 2023 (February 21, 2023) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of inco |
|
| February 21, 2023 |
Amended and Restated Bylaws as approved February 17, 2023, as amended April 27, 2023 AMENDED AND RESTATED BYLAWS OF NATIONAL HEALTH INVESTORS, INC. As adopted February 17, 2023 i AMENDED AND RESTATED BYLAWS OF NATIONAL HEALTH INVESTORS, INC. TABLE OF CONTENTS Page ARTICLE I MEETINGS OF STOCKHOLDERS 1 1.01. PLACE; REMOTE COMMUNICATION 1 1.02. ANNUAL MEETING 1 1.03. SPECIAL MEETINGS 1 1.04. NOTICE 2 1.05. SCOPE OF NOTICE 2 1.06. QUORUM 2 1.07. VOTING 3 1.08. PROXIES 3 1.09. CONDUCT |
|
| February 21, 2023 |
NHI Announces Fourth Quarter 2022 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Fourth Quarter 2022 Results MURFREESBORO, Tenn. – (February 21, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months and year ended December 31, 2022. Financial Results and Recent Events •Net income attributable to common stockholders per diluted common shar |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Health In |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 21, 2023 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 21, 2023 | ||
| February 21, 2023 |
Amendment No. 9 to Master Lease Agreement to Lease with NHC AMENDMENT NO. 9 TO MASTER AGREEMENT TO LEASE This Amendment No. 9 (hereinafter “Amendment No. 9” or “9th Amendment”) is made to that certain Master Agreement to Lease between National Health Investors, Inc. (“Landlord” or “NHI”) and National HealthCare Corporation (f/k/a National HealthCare L.P.) (“Tenant” or “NHC”) dated October 17, 1991, as amended, (“Master Lease”), and is entered into the 29th |
|
| February 21, 2023 |
Exhibit 4.7 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the capital stock of National Health Investors, Inc. (the “Company,” “us,” “our” or “we”) is a summary of the rights of our common stock and certain provisions of Maryland General Corporation Law and our articles of incorporation (our “articles”) and amended a |
|
| February 21, 2023 |
Amendment No. 8 to Master Lease Agreement to Lease with NHC AMENDMENT NO. 8 TO MASTER AGREEMENT TO LEASE This Amendment No. 8 (hereinafter "Amendment No. 8" or "8th Amendment") is made to that certain Master Agreement to Lease between National Health Investors, Inc. ("Landlord" or "NHI") and National HealthCare Corporation (f/k/a National HealthCare L.P.) ("Tenant" or "NHC'') dated October 17, 1991, as amended, ("Master Lease"), and is entered into the 30t |
|
| February 9, 2023 |
NHI / National Health Investors Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 17)* Name of issuer: National Health Investors Inc. Title of Class of Securities: REIT CUSIP Number: 63633D104 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| November 8, 2022 |
Exhibit 99.2 |
|
| November 8, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): November 8, 2022 (November 8, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorp |
|
| November 8, 2022 | ||
| November 8, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 8, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National |
|
| November 8, 2022 |
NHI Announces Third Quarter 2022 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Third Quarter 2022 Results MURFREESBORO, Tenn. ? (November 8, 2022) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2022. Financial Results and Recent Events ?Net income attributable to common stockholders per diluted common share |
|
| November 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 8, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 8, 2022 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Finance & Investor Relations Phone: (615) 890-9100 NHI Issues Business Update MURFREESBORO, Tenn.- (November 8, 2022) - National Health Investors, Inc. (NYSE:NHI) has issued the following business update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real |
|
| September 8, 2022 |
Amendment No. 10 to Master Lease Agreement to Lease with NHC Exhibit 10.1 AMENDMENT NO. 10 TO MASTER AGREEMENT TO LEASE THIS AMENDMENT NO. 10 TO MASTER AGREEMENT TO LEASE (this ?Amendment?) is made as of Sept. 1, 2022 (the ?Amendment Execution Date?) by and between NATIONAL HEALTH INVESTORS, INC., a Maryland corporation (?Landlord?) and NHC/OP, L.P., a Delaware limited partnership (?Tenant?). Landlord and Tenant are collectively referred to herein as the ?P |
|
| September 8, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): September 8, 2022 (September 1, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of inco |
|
| August 9, 2022 |
tors Progress Report, August 8, 2022 Exhibit 99.1 About NHI Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care |
|
| August 9, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): August 8, 2022 (August 8, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporat |
|
| August 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 8, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 8, 2022 |
Fourth Amendment dated June 29, 2022 to Note Purchase Agreement dated November 3, 2015 Execution Version NATIONAL HEALTH INVESTORS, INC. Senior Notes Issuable in Series $50,000,000 3.99% Series 2015-1 Tranche A Senior Notes due 2023 $50,000,000 4.33% Series 2015-1 Tranche B Senior Notes due 2025 $75,000,000 3.93% Series 2016-1 Senior Notes due 2024 FOURTH AMENDMENT TO NOTE PURCHASE AGREEMENT DATED NOVEMBER 3, 2015 Dated June 29, 2022 FOURTH AMENDMENT TO NOTE PURCHASE AGREEMENT This |
|
| August 8, 2022 |
Second Amendment dated September 30, 2016 to Note Purchase Agreement dated November 3, 2015 NATIONAL HEALTH INVESTORS, INC. Senior Notes Issuable in Series $50,000,000 3.99% Series 2015-1 Tranche A Senior Notes due 2023 $50,000,000 4.33% Series 2015-1 Tranche B Senior Notes due 2025 SECOND AMENDMENT TO NOTE PURCHASE AGREEMENT DATED NOVEMBER 3, 2015 Dated September 30, 2016 1181809:3:NASHVILLE SECOND AMENDMENT TO NOTE PURCHASE AGREEMENT This Second Amendment to Note Purchase Agreement (th |
|
| August 8, 2022 |
, 2016 to Note Purchase Agreement dated November 3, 2015 (filed herewith) NATIONAL HEALTH INVESTORS, INC. Senior Notes Issuable in Series $50,000,000 3.99% Series 2015-1 Tranche A Senior Note due November 3, 2023 $50,000,000 4.33% Series 2015-1 Tranche B Senior Notes due November 3, 2025 FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT DATED NOVEMBER 3, 2015 Dated August 15, 2016 1184649:2:NASHVILLE National Health Investors, Inc. 222 Robert Rose Drive Murfreesboro, TN 37129 |
|
| August 8, 2022 |
NHI Announces Second Quarter 2022 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Second Quarter 2022 Results MURFREESBORO, Tenn. ? (August 8, 2022) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2022. Financial Results and Recent Events ?Net income attributable to common stockholders per diluted common share for th |
|
| August 8, 2022 |
Sixth Amendment dated June 29, 2022 to Note Purchase Agreement dated January 13, 2015 Execution Version SIXTH AMENDMENT TO NOTE PURCHASE AGREEMENT THIS FIFTH AMENDMENT TO NOTE PURCHASE AGREEMENT (this ?Amendment?), is made and entered into as of June 29, 2022, by and among National Health Investors, Inc. |
|
| August 8, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 8, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commi |
|
| August 8, 2022 | ||
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Healt |
|
| May 9, 2022 |
EXECUTION VERSION AMENDMENT NO. 1 TO TERM LOAN AGREEMENT This AMENDMENT NO. 1 TO TERM LOAN AGREEMENT (this ?Amendment?) is made and entered into as of March 31, 2022 by and among NATIONAL HEALTH INVESTORS, INC., a corporation formed under the laws of the State of Maryland (the ?Borrower?), each of the financial institutions signatory hereto as Lenders (as defined below), and WELLS FARGO BANK, NATI |
|
| May 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 9, 2022 |
NHI Announces First Quarter 2022 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2022 Results MURFREESBORO, Tenn. ? (May 9, 2022) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2022. Financial Results ?Net income attributable to common stockholders per diluted common share for the three months ended March 31 |
|
| May 9, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): May 9, 2022 (May 6, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) ( |
|
| May 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Heal |
|
| May 9, 2022 | ||
| May 9, 2022 |
EXECUTION VERSION Published CUSIP Number: 63633KAX6 Facility CUSIP Number: 63633KAX6 CREDIT AGREEMENT Dated as of March 31, 2022 by and among NATIONAL HEALTH INVESTORS, INC. |
|
| May 9, 2022 |
EXECUTION COPY FINAL SETTLEMENT AGREEMENT AND RELEASE This Final Settlement Agreement and Release (?Final Settlement Agreement?) is entered into by and between, on one hand, National Health Investors, Inc. |
|
| May 9, 2022 |
NATIONAL HEALTH INVESTORS, INC., AS ISSUER THE GUARANTEEING SUBSIDIARIES PARTY HERETO, THE SUBSIDIARY GUARANTORS PARTY HERETO, AS SUBSIDIARY GUARANTORS AND REGIONS BANK, AS TRUSTEE SECOND SUPPLEMENTAL INDENTURE Dated as of March 31, 2022 SUPPLEMENT TO INDENTURE DATED AS OF JANUARY 26, 2021, BETWEEN NATIONAL HEALTH INVESTORS, INC. (AS ISSUER) AND REGIONS BANK (AS TRUSTEE) SECOND SUPPLEMENTAL INDENT |
|
| May 9, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| May 3, 2022 |
NHI Announces the Appointment of Tracy M. J. Colden to the Board of Directors Contact: Dana Hambly, Vice President, Finance and Investor Relations Phone: (615) 890-9100 NHI Announces the Appointment of Tracy M. |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commissi |
|
| April 18, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): April 18, 2022 (April 15, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporat |
|
| April 18, 2022 |
NHI Provides 2022 Guidance and Announces $240 Million Share Repurchase Plan Contact: Dana Hambly, Vice President, Finance and Investor Relations Phone: (615) 890-9100 NHI Provides 2022 Guidance and Announces $240 Million Share Repurchase Plan MURFREESBORO, Tenn. |
|
| April 4, 2022 |
Exhibit 99.1 Contact: Dana Hambly, Vice President, Investor Relations Phone: (615) 890-9100 NHI Provides Business Update MURFREESBORO, Tenn.- (April 4, 2022) - National Health Investors, Inc. (NYSE:NHI) today provided a business update regarding recent portfolio activity, monthly rent concessions and contractual cash collections, and average occupancy from three large senior housing operators thro |
|
| April 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): April 4, 2022 (March 31, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporati |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2022 NATIONAL HEALTH INVESTORS, INC. (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| March 30, 2022 |
EX-FILING FEES 3 d293039dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) National Health Investors, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule(1) Amount Registered(2) Proposed Maximum Offering Price Per Un |
|
| March 30, 2022 |
As filed with the Securities and Exchange Commission on March 30, 2022 As filed with the Securities and Exchange Commission on March 30, 2022 Registration No. |
|
| March 25, 2022 |
DEF 14A 1 a2022def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ x ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Us |
|
| March 7, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): March 7, 2022 (March 7, 2022) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporatio |
|
| March 7, 2022 |
NHI Announces Memorandum of Understanding in Litigation Related to Legacy Holiday Properties Exhibit 99.1 Contact: Dana Hambly, Vice President, Investor Relations Phone: (615) 890-9100 NHI Announces Memorandum of Understanding in Litigation Related to Legacy Holiday Properties MURFREESBORO, Tenn.- (March 7, 2022) - National Health Investors, Inc. (NYSE:NHI) announced today that it has entered into a memorandum of understanding (the ?MOU?) related to the previously disclosed lawsuit styled |
|
| February 22, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 22, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 22, 2022 |
NHI Announces Fourth Quarter 2021 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Fourth Quarter 2021 Results MURFREESBORO, Tenn. ? (February 22, 2022) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months and year ended December 31, 2021. Financial Results ?Net income attributable to common stockholders per diluted common share for the year end |
|
| February 22, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 22, 2022 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Co |
|
| February 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National Health In |
|
| February 22, 2022 |
Supplemental Information for the year ended December 31, 2021, dated February 22, 2022 |
|
| February 22, 2022 |
Exhibit 21 Subsidiary Entity List Entity Name Ownership1 Tax Treatment NHI/REIT, Inc. |
|
| February 10, 2022 |
NHI / National Health Investors Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 16)* Name of issuer: National Health Investors Inc. Title of Class of Securities: REIT CUSIP Number: 63633D104 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| November 8, 2021 | ||
| November 8, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 8, 2021 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 8, 2021 |
NHI Announces Third Quarter 2021 Results Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Third Quarter 2021 Results MURFREESBORO, Tenn. ? (November 8, 2021) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2021. Financial Results ?Net income attributable to common stockholders per diluted common share for the three mon |
|
| November 8, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 8, 2021 National Health Investors Inc (Exact name of Registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Com |
|
| November 8, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): November 8, 2021 (November 8, 2021) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorp |
|
| November 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-10822 National |
|
| November 8, 2021 |
Exhibit 99.1 |
|
| October 6, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): October 6, 2021 (September 30, 2021) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incor |
|
| October 6, 2021 |
Exhibit 10.1 FOURTH AMENDMENT TO MASTER LEASE THIS FOURTH AMENDMENT TO MASTER LEASE (the "Amendment") is effective as of September 30, 2021 (the "Effective Date"), by and among NHI-REIT OF NEXT HOUSE, LLC, a Delaware limited liability company (?NRNH?), MYRTLE BEACH RETIREMENT RESIDENCE LLC, an Oregon limited liability company (?MBRR?) and VOORHEES RETIREMENT RESIDENCE LLC, an Oregon limited liabil |
|
| August 25, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): August 25, 2021 (August 25, 2021) NATIONAL HEALTH INVESTORS INC (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorpor |
